Urinary Tract Obstruction Treatment & Management

  • Author: Edward David Kim, MD, FACS; Chief Editor: Bradley Fields Schwartz, DO, FACS   more...
 
Updated: Dec 5, 2011
 

Medical Therapy

Consultation with a urologist should be obtained in patients with urinary tract obstruction, as in hydronephrosis or urinary retention. A patient with complete urinary tract obstruction; any type of obstruction in a solitary kidney; obstruction with fever or infection; or renal failure needs immediate attention by a urologist. Patients with pain that is uncontrolled with oral medications or with persistent nausea and vomiting that causes dehydration also need immediate urological attention.

A partial urinary tract obstruction in the absence of infection can be initially managed with analgesics and prophylactic antibiotics until a complete urologic evaluation is performed and definitive management is completed.

Antibiotics are often given for prophylaxis and should cover common urinary tract pathogens. Commonly used antibiotics include trimethoprim-sulfamethoxazole, nitrofurantoin, cephalosporins, and fluoroquinolones.

Pain secondary to urinary tract obstruction is often managed with oxycodone, hydrocodone, acetaminophen, and nonsteroidal anti-inflammatory medications.

Next

Surgical Therapy

The goal of surgical intervention is to completely relieve the urinary tract obstruction. This can be evaluated with reimaging to ensure that the obstruction is resolved, as well as renal function monitoring with a creatinine laboratory test. The recovery of renal function depends on the severity and duration of the obstruction.

Different interventions can be performed to temporarily relieve the point of obstruction. Surgical intervention is usually obtained once the point of obstruction is identified with radiographic imaging.

Lower urinary tract obstruction (bladder, urethra) can be relieved with the following:

  • Urethral catheter
    • A urethral catheter (size 8F-24F) is a flexible external catheter that extends from the bladder through the urethra.
    • A physician or nurse can place it. If catheter placement is difficult, a urologist may be needed to avoid urethral trauma. The urologist may need to perform urethral dilation, cystoscopy, or both to pass the catheter.
    • The catheter can be left indwelling, or, as an alternative, the patient can perform clean intermittent catheterization.
    • If blood is present at the urethral meatus after pelvic trauma and suspicion of urethral injury exists, a urologist should be consulted prior to catheter placement. Retrograde urethrography needs to be performed to rule out urethral injury.
  • Suprapubic tube or catheter: If a Foley catheter cannot be passed, a suprapubic tube can be placed percutaneously (at the bedside) or in an open fashion (in the operating room). A suprapubic tube is placed on the lower anterior abdominal wall, approximately 2 finger-breadths above the pubic symphysis. Ultrasound guidance should be used for bedside procedures to ensure proper placement without injury to adjacent structures. In patients with previous abdominal surgery, adhesions and scar tissue may have changed the normal bowel location, so an open approach may be preferred.

Upper urinary tract obstruction (ureter, kidney) can be relieved with the following:

  • Ureteral stent: A ureteral stent is a flexible tube that extends from the renal pelvis to the bladder. It can be placed during cystoscopy to relieve obstruction along any point in the ureter. A ureteral stent generally needs to be changed every 3 months.
  • Nephrostomy tube: A nephrostomy tube is a flexible tube that is placed through the back directly into the renal pelvis. If a ureteral stent cannot be placed cystoscopically in a retrograde fashion, a percutaneous nephrostomy tube can be inserted for relief of hydronephrosis. If needed, a ureteral stent can then be passed in an antegrade fashion through the nephrostomy tube tract.

The following are urologic emergencies that require immediate attention and intervention:

  • Complete urinary tract obstruction
  • Any type of obstruction in a solitary kidney
  • Obstruction with fever, infection, or both
  • Renal failure
  • Pain that is uncontrolled with oral medications
  • Nausea and vomiting that causes dehydration
Previous
Next

Preoperative Details

Before any surgical intervention or any manipulation of the urinary tract, broad-spectrum antibiotics should be initiated to prevent infection or urosepsis. Ideally, before any manipulation is performed, the urine should be sterile. However, this may not be possible in cases of emergent surgical intervention. Urine culture along with the administration of broad-spectrum antibiotics is important.

If cystoscopy and stent are needed emergently, coagulation is not a concern. If percutaneous drainage is necessary, coagulopathies should be corrected.

Previous
Next

Intraoperative Details

Different interventions can be performed to temporarily relieve the point of obstruction. If the planned procedure cannot be performed safely or is not adequate in relieving urinary tract obstruction, other modes of urinary tract decompression can be tried.

Previous
Next

Postoperative Details

When a patient has long-standing urinary tract obstruction that has been relieved, they may experience postobstructive diuresis.[4] This physiologic diuresis is usually self-limiting and can be managed conservatively with fluid replacement and, if needed, electrolyte replacement. Postobstructive diuresis is defined as diuresis of more than 200 mL/h for at least 2 hours. Patients with severe diuresis should receive intravenous fluid replacement in the form of half normal saline at 80% of the hourly urine volume for the first 24 hours, then 50%. Postobstructive diuresis usually lasts 24-72 hours. Most cases are not severe enough to require this level of attention.

Previous
Next

Follow-up

Definitive treatment at the point of obstruction is needed after the acute obstruction is resolved. Adults and children often have different etiologies of urinary tract obstruction. Thus, various definitive surgical treatment options are available for each condition. After definitive treatment is achieved, a final imaging study is obtained to verify complete relief of the obstruction. The type of study performed, as well as the timing of the study, is left to the discretion of the urologist.

For excellent patient education resources, visit eMedicine's Kidneys and Urinary System Center. Also, see eMedicine's patient education articles Intravenous Pyelogram, Cystoscopy, Magnetic Resonance Imaging (MRI), and CT Scan.

Previous
Next

Complications

A patient with urinary tract obstruction should see a urologist promptly because of the serious complications that the obstruction can impose. The following are complications of obstructive uropathy:

  • Infection, including cystitis (bladder infection), pyelonephritis (kidney infection), abscess formation, and urosepsis
  • Urinary extravasation with urinoma formation
  • Urinary fistula formation
  • Renal insufficiency or failure
  • Bladder dysfunction secondary to a defunctionalized bladder
  • Pain
Previous
Next

Outcome and Prognosis

The prognosis of urinary tract obstruction depends on the cause, location, degree, and duration of obstruction, as well as the presence of a urinary tract infection. The longer the duration of obstruction, the greater the severity of obstruction, and the presence of a concomitant infection can lead to a worse prognosis. The prognosis is favorable if the renal function is normal, the infection is cleared, and the obstruction is relieved in a timely manner.

Previous
Next

Future and Controversies

As time goes on, new procedures emerge and old procedures are modified to relieve urinary tract obstruction. In addition, with newer cameras and equipment and the use of laparoscopy, surgical intervention is becoming more advanced.

Previous
 
Contributor Information and Disclosures
Author

Edward David Kim, MD, FACS  Professor of Surgery, Division of Urology, University of Tennessee Graduate School of Medicine; Consulting Staff, University of Tennessee Medical Center

Edward David Kim, MD, FACS is a member of the following medical societies: American College of Surgeons, American Society for Reproductive Medicine, American Society of Andrology, American Urological Association, Sexual Medicine Society of North America, and Tennessee Medical Association

Disclosure: Lilly Consulting fee Advisor; Astellas Consulting fee Speaking and teaching; Watson Consulting fee Speaking and teaching; Allergan Consulting fee Speaking and teaching

Coauthor(s)

Yvonne Katherine P Koch, MD  Physician, Department of Urology, Case Western Reserve University, University Hospitals of Cleveland

Yvonne Katherine P Koch, MD is a member of the following medical societies: American Urological Association and Endourological Society

Disclosure: Nothing to disclose.

Suzette E Sutherland, MD  Adjunct Associate Professor, Department of Urologic Surgery, University of Minnesota Medical School; Metro Urology, Centers for Continence Care and Female Urology

Suzette E Sutherland, MD is a member of the following medical societies: Alpha Omega Alpha, American Medical Association, American Urological Association, International Continence Society, International Society for Sexual Medicine, and Minnesota Medical Association

Disclosure: Nothing to disclose.

Specialty Editor Board

Francisco Talavera, PharmD, PhD  Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Medscape Salary Employment

J Stuart Wolf Jr, MD, FACS  The David A Bloom Professor of Urology, Director, Division of Endourology and Stone Disease, Department of Urology, University of Michigan Medical School

J Stuart Wolf Jr, MD, FACS is a member of the following medical societies: American College of Surgeons, American Urological Association, Catholic Medical Association, Endourological Society, Society for Urology and Engineering, Society of Laparoendoscopic Surgeons, Society of University Urologists, and Society of Urologic Oncology

Disclosure: Nothing to disclose.

Chief Editor

Bradley Fields Schwartz, DO, FACS  Professor of Urology, Director, Center for Laparoscopy and Endourology, Department of Surgery, Southern Illinois University School of Medicine

Bradley Fields Schwartz, DO, FACS is a member of the following medical societies: American College of Surgeons, American Urological Association, Association of Military Osteopathic Physicians and Surgeons, Endourological Society, Society of Laparoendoscopic Surgeons, and Society of University Urologists

Disclosure: Nothing to disclose.

Additional Contributors

The authors and editors of eMedicine gratefully acknowledge the contributions of previous coauthor Martin I Resnick, MD, to the development and writing of this article.

References
  1. Zaccara A, Pascali MP, Marciano A, Carnevale E, Salvatori G, Dotta A, et al. VURD Syndrome in a Female. Adv Urol. 2011;2011:852928. [Medline]. [Full Text].

  2. Abdul-Rahman A, Al-Hayek S, Belal M. Urodynamic studies in the evaluation of the older man with lower urinary tract symptoms: when, which ones, and what to do with the results. Ther Adv Urol. Oct 2010;2(5-06):187-94. [Medline]. [Full Text].

  3. Asgari SA, Mohammadi M. The role of intraprostatic inflammation in the acute urinary retention. Int J Prev Med. Jan 2011;2(1):28-31. [Medline]. [Full Text].

  4. Loo MH, Vaughan ED. Obstructive nephropathy and postobstructive diuresis. AUA Update Series. 1985;4:9.

  5. Campbell SC, Walsh PC. Pathophysiology of urinary tract obstruction. In: Wein J, ed. Campbell-Walsh Urology. Vol 2. 9th ed. Saunders; 2007:1195-226.

  6. Chen MY, Zagoria RJ, Dyer RB. Radiologic findings in acute urinary tract obstruction. J Emerg Med. May-Jun 1997;15(3):339-43. [Medline].

  7. Follis HW, Koch MO, McDougal WS. Immediate management of prostatomembranous urethral disruptions. J Urol. May 1992;147(5):1259-62. [Medline].

  8. Franke JJ, Smith JA. Surgery of the ureter. In: Walsh PC, Retik AB, eds. Campbell's Urology. 7th ed. Philadelphia, Pa: WB Saunders and Co; 1998.

  9. Gulmi FA, Felsen D, Vaughan ED. The pathophysiology of urinary tract obstruction. In: Walsh PC, Retik AB, eds. Campbell's Urology. 7th ed. Philadephia, Pa: WB Saunders and Co; 1998:342-385.

  10. Hampel N. Posterior urethral disruption associated with pelvic fracture: the place for delayed repair. Semin Urol. Feb 1995;13(1):34-7. [Medline].

  11. Kabalin JN. Surgical anatomy of the retroperitoneum, kidneys, and ureters. In: Walsh PC, Retik AB, eds. Campbell's Urology. 7th ed. Philadelphia, Pa: WB Saunders and Co; 1998.

  12. Lefort C, Marouteau-Pasquier N, Pesquet AS, Pfister C, Vera P, Dacher JN. Dynamic MR urography in urinary tract obstruction: implementation and preliminary results. Abdom Imaging. Mar-Apr 2006;31(2):232-40. [Medline].

  13. Lloyd-Davies RW. Landmarks in the History of Urology. In: Weiss RM, George NJR, O'Reilly PH, eds. Comprehensive Urology. England, UK: Mosby; 2001:1-14.

  14. Macfarlane MT. Obstructive uropathy. In: Urology. 2nd ed. Philadelphia, Pa: Williams & Wilkins; 1995:97-102.

  15. McNaughton-Collins M, Barry MJ. Managing patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia. Am J Med. Dec 2005;118(12):1331-9. [Medline].

  16. Resnick MI, Kursh ED. Extrinsic obstruction of the ureter. In: Walsh PC, Retik AB, eds. Campbell's Urology. Vol 1. Philadelphia, Pa: WB Saunders and Co; 1998:387-422.

  17. Sty JR, Pan CG. Genitourinary imaging techniques. Pediatr Clin North Am. Jun 2006;53(3):339-61, v. [Medline].

  18. Tanagho EA. Urinary obstruction and stasis. In: Tanagho EA, McAninch JW, eds. Smith's General Urology. New York, NY: McGraw-Hill; 1995:172-185.

  19. Thomas AW, Cannon A, Bartlett E, et al. The natural history of lower urinary tract dysfunction in men: minimum 10-year urodynamic follow-up of untreated bladder outlet obstruction. BJU Int. Dec 2005;96(9):1301-6. [Medline].

  20. Thomas AW, Cannon A, Bartlett E, et al. The natural history of lower urinary tract dysfunction in men: minimum 10-year urodynamic followup of transurethral resection of prostate for bladder outlet obstruction. J Urol. Nov 2005;174(5):1887-91. [Medline].

Previous
Next
 
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.